CCNJ and breast carcinoma: Venturutti, L. et al. further suggest that the inhibition of CCNJ could repair the proliferation of breast carcinoma (BC) and gastric carcinoma (GC) cells in vitro and promote chemosensitive to trastuzumab and lapatinib in preclinical BC model [50].